Idacta mAb INT-001 represents the interesting medicinal strategy for treating selected blood-related cancers. This antibody shows an distinct process of action, particularly interacting with CD-38, the membrane antigen https://deaconoezx599826.wikipresses.com/7350674/idacta_mab_int_001_a_innovative_antigen_binding_protein_under_progression